MicrobiologybioRxiv
SapM mutation to improve the BCG vaccine: genomic, transcriptomic and preclinical safety characterization
N. Festjens, K. Vandewalle, E. Houthuys…·N. Callewaert
The paper characterizes a BCG vaccine mutant with a SapM mutation, showing improved safety and immune control, supporting its potential as a live attenuated TB vaccine.
DOI 10.1016/j.vaccine.2019.05.022